Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants

Not Applicable

Completed

Conditions: Necrotizing Enterocolitis

First Posted Date: 2005-11-11

Last Posted Date: 2006-07-21

Lead Sponsor: Yale University

Target Recruit Count: 130

Registration Number: NCT00252681

Locations: 🇺🇸
Yale University School of Medicine Section of Pediatric Surgery, New Haven, Connecticut, United States

Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack

Phase 2

Completed

Conditions: Transient Ischemic Attack
Sleep Apnea

First Posted Date: 2005-11-09

Last Posted Date: 2009-03-03

Lead Sponsor: Yale University

Target Recruit Count: 62

Registration Number: NCT00251290

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut, United States
🇺🇸
Hospital of St. Raphael, New Haven, Connecticut, United States
🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled Trial

Not Applicable

Completed

Conditions: Otitis Media

First Posted Date: 2005-11-08

Last Posted Date: 2006-11-30

Lead Sponsor: Yale University

Target Recruit Count: 240

Registration Number: NCT00250900

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Aripiprazole Treatment of Prodromal Patients

Phase 2

Completed

Conditions: Schizophrenia
Psychosis

First Posted Date: 2005-10-12

Last Posted Date: 2014-06-06

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT00237874

Locations: 🇺🇸
Institute of Living, Hartford, Connecticut, United States
🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia

First Posted Date: 2005-10-12

Last Posted Date: 2014-06-06

Lead Sponsor: Yale University

Registration Number: NCT00237861

Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension

Phase 1

Terminated

Conditions: Hemodialysis
Hypotension

Interventions: Drug: dialysate sodium (140 mmol/L)
Drug: individualized dialysate sodium

First Posted Date: 2005-10-12

Last Posted Date: 2016-07-26

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT00237783

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Phase 3

Completed

Conditions: Schizoaffective Disorder
Schizophrenia

Interventions: Drug: Placebo
Drug: D-serine
Behavioral: Cognitive Retraining (CRT)
Behavioral: Cognitive Retraining Placebo

First Posted Date: 2005-10-12

Last Posted Date: 2017-05-10

Lead Sponsor: Yale University

Target Recruit Count: 104

Registration Number: NCT00237809

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia

Phase 3

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

First Posted Date: 2005-10-12

Last Posted Date: 2012-06-18

Lead Sponsor: Yale University

Target Recruit Count: 72

Registration Number: NCT00237848

Locations: 🇮🇳
National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India

Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders

Phase 2

Completed

Conditions: Psychiatric Diagnosis
Diagnosis, Dual (Psychiatry)
Drug Use Disorders

First Posted Date: 2005-10-12

Last Posted Date: 2017-10-17

Lead Sponsor: Yale University

Target Recruit Count: 75

Registration Number: NCT00237822

Locations: 🇺🇸
Yale University Substance Abuse Center, New Haven, Connecticut, United States

Culturally Responsive Person-Centered Care for Psychosis

Phase 1

Completed

Conditions: Psychotic Disorders

Interventions: Behavioral: Illness management recovery (IMR)
Behavioral: Person-centered planning (PCP)
Behavioral: Community integration (CI)

First Posted Date: 2005-10-04

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 290

Registration Number: NCT00231933

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy